Products
Images
Epitopes
New
Building a flow cytometry panel? Try Panel Builder

BTLA (CD272) Antibodies

Antibodies that detect BTLA (CD272) can be used in several scientific applications, including Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry and ELISA. These antibodies target BTLA (CD272) in Human, Mouse and Rat samples. Our BTLA (CD272) monoclonal, polyclonal and recombinant monoclonal antibodies are developed in Mouse, Rabbit and Goat. These antibodies have been verified by Relative expression to confirm specificity to BTLA (CD272). Find the BTLA (CD272) antibody that fits your needs. Choose from 1 of 59 BTLA (CD272) antibodies, which have been validated in experiments with 22 publications and 132 images featured in our data ... View more Antibodies that detect BTLA (CD272) can be used in several scientific applications, including Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry and ELISA. These antibodies target BTLA (CD272) in Human, Mouse and Rat samples. Our BTLA (CD272) monoclonal, polyclonal and recombinant monoclonal antibodies are developed in Mouse, Rabbit and Goat. These antibodies have been verified by Relative expression to confirm specificity to BTLA (CD272). Find the BTLA (CD272) antibody that fits your needs. Choose from 1 of 59 BTLA (CD272) antibodies, which have been validated in experiments with 22 publications and 132 images featured in our data gallery.

Browse primary antibodies for WB, Flow, IHC, ICC/IF, ELISA, IP, and other applications. Antibodies with Advanced Verification data have been validated for specificity to ensure that the antibody binds to the antigen stated. If you cannot find the antibody you're looking for, contact us today to develop custom antibodies for specific targets, species and applications.

Target Information

BTLA or B and T-lymphocyte attenuator is a member of the co-inhibitory receptors of the CD28 superfamily. BTLA is a lymphocyte inhibitory receptor which inhibits lymphocytes during immunes responses. BTLA is constitutively expressed on most CD4+ and CD8+ T cells and its expression progressively decreases upon T cell activation. It remains expressed on Th1 cells, but not Th2 cells. BTLA is a unique co-receptor that interacts with the tumor necrosis factor receptor superfamily member herpesvirus entry mediator (HVEM). This interation is an important pathway regulating lymphocyte activation and/or homeostasis in the immune response.

Synonyms

A630002H24; B and T lymphocyte associated; B and T lymphocyte associated protein; B and T lymphocyte attenuator; B- and T-lymphocyte attenuator; B- and T-lymphocyte-associated protein; BTLA; BTLA_HUMAN; BTLA1; CD272; CD272 antigen; FLJ16065; MGC129743

Target Video

6320246791112

BTLA (CD272) antibodies from Thermo Fisher Scientific

https://cf-images.us-east-1.prod.boltdns.net/v1/static/3663210762001/801be4f7-8ac2-4d3e-a7e9-4b32113da64b/fcc25611-6eb6-47b2-b0d2-d0306e1cc4f4/320x180/match/image.jpg

Learn more about BTLA (CD272) primary antibodies that can be used in Western Blot, Flow Cytometry, Immunohistochemistry and Immunocytochemistry in Human, Mouse and Rat samples.